ENCORI (http://starbase.sysu.edu.cn/index.php) shows that CPSF6 is upregulated in patients with HCC and is associated with poor prognosis (Additional file 1: Figure S1A, B). Here, CPSF6 is linked to hepatocellular carcinoma.